Ines N.
- Country
- Portugal
- Department
- Serviço de Nefrologia
Research Overview
- A Phase 2a Study to Evaluate the Safety and Efficacy of ABBV-142 in Adults with Idiopathic Pulmonary Fibrosis
- Long-term Safety and Efficacy Evaluation of Oral BI 1015550 in Patients with Idiopathic and Progressive Pulmonary Fibrosis
- Efficacy and Safety Evaluation of Bexotegrast in Idiopathic Pulmonary Fibrosis: A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study
Data & Insights
Has run more than one trial at 109 of 201 partner sites.
Specializations
Pulmonary Fibrosis Research
This investigator specializes in the study of idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF), conducting extensive research into innovative therapeutic approaches for these chronic lung conditions.
- Idiopathic Pulmonary Fibrosis Management
- Progressive Fibrotic Lung Disease Treatment
- Long-term Disease Monitoring
The investigator focuses on evaluating novel therapeutic agents for treating various forms of pulmonary fibrosis.
Interstitial Lung Disease Studies
Specializing in Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs), the investigator examines therapeutic interventions aimed at improving lung function and reducing disease progression.
- Lung Function Assessment
- Disease Progression Monitoring
- Treatment Efficacy Evaluation
Research activities center on assessing innovative treatments for various forms of progressive lung disorders.
Clinical Safety Assessment
The investigator conducts comprehensive evaluations of treatment tolerability and therapeutic safety profiles in patients with various forms of pulmonary fibrosis.
- Long-term Safety Monitoring
- Adverse Event Assessment
- Treatment Response Evaluation
Focus includes systematic assessment of therapeutic interventions and their long-term effects on patient outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.